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ABSTRACT A thorough understanding of the structure of fusion domains of enveloped viruses in changing lipid environments
helps us to formulate mechanistic models on how they might function in mediating viral entry by membrane fusion. We have
expressed the N-terminal fusion domain of HIV-1 gp41 as a construct that is water-soluble in the absence of membranes, but
that also binds with high afﬁnity to lipid micelles and bilayers in their presence. We have solved the structure and studied the
dynamics of this domain bound to dodecylphosphocholine micelles by homo- and heteronuclear NMR spectroscopy. The fusion
peptide forms a stable hydrophobic helix from Ile4 to Ala14, but is increasingly more disordered and dynamic in a segment of
intermediate polarity that stretches from Ala15 to Ser23. When bound to lipid bilayers at low concentration, the HIV fusion domain
is also largelya-helical, as determined byCDandFTIR spectroscopy. However, at higher protein/lipid ratios, the domain is partially
converted to formb-structures in lipid bilayers.Controlled lipidmixingoccurs at concentrations that support thea-helical, but not the
b-strand conformation.
INTRODUCTION
Like many other enveloped viruses, human immunodeﬁ-
ciency virus (HIV) enters cells by binding to receptors on the
surface of susceptible cells followed by fusion of the viral
envelope with the cell’s plasma membrane. HIV binds to and
infects cells that express the receptor CD4 and a chemokine
co-receptor such as CCR5 or CXCR4. These receptors are
recognized by the gp120 subunit of the surface-expressed viral
spike glycoprotein gp120/gp41. Receptor and co-receptor
recognition triggers a conformational change in gp120/gp41,
which in turn initiates the merging of the viral and cell mem-
branes by membrane fusion. The gp41 subunits of the gp120/
gp41 trimer are thought to be primarily responsible for the
fusion reaction. Indeed, a major restructuring of the gp41
subunits occurs because of receptor binding (1–3). This
conformational change exposes the hydrophobic N-terminal
domain of gp41 to the cell surface and makes it available for
binding and insertion into the lipid bilayer of the target cell
membrane (4). Since hydrophobic domains like the one
observed at the N-terminus of gp41 are highly conserved
within but not across different enveloped virus families and
since even very minor mutations in their sequences can lead
to severe defects in membrane fusion, these domains have
been termed ‘‘fusion peptides.’’ It has been shown for a few
viruses, most notably inﬂuenza virus, that their fusion pep-
tides are the major domains besides the C-terminal trans-
membrane domains that interact with the lipid bilayers of the
fused membranes. The other domains (ectodomains) prob-
ably interact only minimally with lipid bilayers, although
some sequences of the intraviral C-terminal domain of gp41
form strongly amphipathic membrane-interactive helices that
may contribute to the mechanism of gp41-mediated mem-
brane fusion (5).
The fusion domain or fusion peptide of HIV-1 gp41
comprises ;15 apolar residues followed by another eight
moderately polar residues (Fig. 1). A determination of the
structure of this domain in lipid bilayers or other membrane-
mimetic environments and biophysical studies of its inter-
action with membranes should help us to better understand
how this domain might help fusing two otherwise inert
membranes. Unfortunately, the strong apolar nature of the
HIV fusion peptide causes it to not only strongly associate
with lipid bilayers, but also endows it with a high propensity
for self-association in solution. These properties have com-
plicated the structural analysis and biophysical interaction
studies with membranes and are probably the root cause for
many diverging reports on this topic in the literature. It seems
quite clear that the size, the model membrane system, the
hydration state, solvents used for preparing peptide-lipid com-
plexes, and other environmental factors contribute some-
times critically to the observed results. Early CD and FTIR
studies using either short peptide models or peptide-lipid
complexes at low protein concentration indicated that these
peptides inserted as oblique helices into lipid model
membranes (6–8). Later investigations with longer peptide
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models favored a transition to b-sheet structures at higher
protein/lipid ratios (6,9) and concluded that the ability to
form b-structures correlated with the ability of these domains
to fuse liposomes (10,11). Conformational mapping by isotope-
edited FTIR spectroscopy indicated an a-helical structure
of the ﬁrst 16 residues of the gp41 fusion domain in lipid
bilayers at moderate protein/lipid ratios (12). However, fu-
sion domains in solution or in the presence of lipid bilayers
at high protein concentrations aggregated into b-sheets (12).
To disperse the hydrophobic fusion domains in solution, they
were often added from organic solvents to lipids in organic
solvent or to preformed liposomes in aqueous solution in
the studies described so far. Structural studies by solid-state
NMR conﬁrmed that fusion domains bound to mixed lipid
bilayers containing cholesterol at protein/lipid molar ratios
between 1:20 and 1:200 and measured at 50C formed ex-
tended b-strands (13). Subsequent solid-state NMR REDOR
experiments of the same fusion domain and a variant with
three C-terminally attached lysines established that the
membrane-bound b-strands aggregated in parallel and anti-
parallel arrangements, which were each approximately equally
populated (14). The fusion domains with the trilysine tags
were shown to be soluble and monomeric in the aqueous
phase before they were bound to the bilayers and the protein-
lipid complexes were pelleted for the solid-state NMR mea-
surements (15). Even though physiological lipid mixtures
were used in these studies, concerns remain that the peptides
may have been expelled from the membrane when they were
cooled to50C, where most lipids form phases with highly
ordered acyl chains. In contrast to the work in bilayers by
solid-state NMR, solution-state NMR of short and long
fusion domain constructs in SDS micelles favored helical
conformations even at the relatively high protein concentra-
tions that are needed for NMR (16,17). The questions then
arise whether the strong ionic detergent SDS is too harsh to
represent the structure of the fusion domain in membranes
and whether the structures observed in bilayers are repre-
sentative of structures that are physiologically delivered to
lipid bilayers in the liquid-crystalline state through aqueous
environments. DPC is a much milder detergent than SDS; it
shares its phosphocholine headgroup with that of the most
abundant phospholipid class in cell membranes. Previous
work also showed that the HIV fusion domain remained
a-helical in DPC, but the samples were either not stable
enough (17) or the homonuclear resonance lines were not
resolved well enough for a complete structure determination
by NMR (18) in DPC micelles that were successful for
solving the structure of the inﬂuenza hemagglutinin fusion
domain (19). Adding a highly polar tag to the C-terminus of
the fusion domain dramatically increases its solubility and
permits binding of the domain to micelles or lipid bilayers
from solution rather than from organic solvents (20). This
strategy has proven key to the success with the structure
determination of wild-type and several mutant inﬂuenza
fusion domains (21) and has also been employed by Jaroniec
et al. (17) and in the solid-state NMR work by Yang et al.
(14,15). We have made a construct consisting of the ﬁrst 23
residues of the fusion domain linked to a pentalysine moiety
with a ﬂexible triple-glycine linker (Fig. 1). This protein
domain is soluble in aqueous buffers and binds strongly
to lipid micelles and bilayers. Its structure and dynamics
were determined by solution NMR in DPC micelles and its
conformational plasticity was examined by CD and FTIR
spectroscopy in lipid bilayers. Our data indicate that the
monomeric helical structure remains helical in bilayers at
low concentrations, but converts to structures containing
substantial amounts of b-sheet at higher protein concentra-
tions in lipid bilayer model membranes. Fusion domain
concentrations that form a-helices are sufﬁcient to mediate
efﬁcient fusion (lipid mixing) of model membranes.
MATERIALS AND METHODS
Expression and puriﬁcation of HIV-1 gp41 fusion
domain for NMR studies
The fusion protein construct used for expression of the HIV fusion domain
consisted of KSI-M-P23H8-M-His6, in which KSI is the 125 amino-acid
ketosteroid isomerase, M is methionine, P23H8 is the fusion domain con-
sisting of the 23 most N-terminal residues of HIV-1 gp41 (LAVmal strain)
and the eight-residue host peptide of three glycines and ﬁve lysines, and
His6 is a hexahistidine-tag for puriﬁcation. Methionines were introduced
before and after the fusion domain as cut sites to remove KSI and the His tag.
The DNA template was synthesized by the Biomolecular Research Facility
FIGURE 1 Strategy for expression and puriﬁcation of a soluble version of
the HIV-1 gp41 fusion domain. See text for details.
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at the University of Virginia. The single methionine residue in position 19
of the wild-type sequence of the fusion domain was mutated to a valine with
the QuikChange site-directed mutagenesis kit (Stratagene, La Jolla, CA)
to avoid cleavage at this position. The ﬁnal expression plasmid was con-
structed by inserting P23H8-M-His6 coding sequence at the AlwNI site of
the pET31b(1)vector (Novagen, Madison, WI). The plasmid was trans-
formed into BLR(DE3)pLysS cells for large scale expression. 15N-labeled
protein was expressed in EMBL minimal media supplemented with (15NH4)2
SO4 and
15N-labeled Bioexpress (Cambridge Isotope Laboratories, Andover,
MA). The cells were induced with 1 mM IPTG at an OD600 of 0.3–0.5 at 37C
and grown for another 4 h.
Harvested cells were resuspended in binding buffer (5 mM imidazole, 40
mM Tris-HCl, 500 mM NaCl, pH 7.9), sonicated on ice until no longer
viscous, and centrifuged at 12,000 g for 10 min at 4C. The majority of the
KSI-M-P23H8-M-His6 protein was found as inclusion bodies in the in-
soluble fraction, and was extracted with binding buffer containing 6 M
guanidinium-HCl. The dissolved material was loaded on a nickel afﬁnity
column, and washed with six bed volumes of washing buffer (16 mM
imidazole, 40 mM Tris-HCl, 500 mM NaCl, pH 7.9) containing 6 M
guanidinium-HCl. The fusion protein was eluted from the column with six
bed volumes of elution buffer (300 mM imidazole, 40 mM Tris-HCl, 500 mM
NaCl, pH 7.9) containing 6 M guanidinium-HCl. Three-milliliter fractions
were collected and the peak fractions (;12 ml) were combined and dialyzed
overnight at room temperature against three 1-liter changes of H2O in 8000
cut-off dialysis bags. The majority of the protein formed a white precipitate
and was pelleted by centrifugation at 2000 g for 10 min at 4C. To remove
the KSI fusion protein and His-tag from the fusion domain, the dense
white pellet was dissolved in 50% triﬂuoroacetic acid/H2O, and 100 mol
CNBr for each mol of methionine (there are four methionines in the whole
construct) was added to the solution. After stirring overnight at room
temperature under nitrogen and in the dark, the reactant mixture was diluted
10-fold with water and lyophilized. The powder was dissolved in 30%
CH3CN/H2O and puriﬁed by reverse-phase HPLC (Beckman Coulter,
Fullerton, CA) on a model No. 218TP510 column (Grace-Vydac, Deerﬁeld,
IL) with a gradient of water/acetonitrile containing 0.1% triﬂuoroacetic acid.
Peptide homogeneity and identity were analyzed by analytical HPLC and
matrix-assisted laser desorption/ionization time-of-ﬂight mass spectroscopy,
respectively, and the purity was estimated .95%. CNBr cleavage results in
a homoserine lactone instead of free carboxyl group at the C-terminus of
P23H8 (see Fig. 1). The puriﬁed fusion domain was lyophilized and stored at
20C before further use.
Liposomes
Small unilamellar vesicles were prepared by mixing four parts of POPC and
one part of POPG (Avanti Polar Lipids, Alabaster, AL) in chloroform,
evaporating the solvent under a stream of nitrogen, followed by evacuation
for .3 h to remove residual solvent. The lipid dispersions were rehydrated
and vortexed in 5 mM HEPES, 10 mM MES buffer, pH 7.4, followed by
sonication with a probe sonicator for 45 min at 50% duty cycle on an ice-water
bath. Large unilamellar vesicles of the same composition were prepared by
extrusion (15 passes) of the vortexed and freeze-thawed (ﬁve cycles) lipid
dispersions through two polycarbonate membranes (100 nm pore size) using a
Liposofast extruder (Avestin, Ottawa, ON).
Lipid mixing assay for membrane fusion
Membrane fusion was measured by ﬂuorescence resonance energy transfer
(22) using a Fluorolog-3 spectroﬂuorometer (Jobin-Yvon, Edison, NJ).
Two populations of large unilamellar vesicles composed of POPC/POPG
(4:1), one unlabeled and one labeled with 1% each of n-[7-nitro-2-1,3-
benzoaxadiazole-4-yl]-egg-phosphatidylethanolamine and n-[lissamine rho-
damine B]-egg-phosphatidylethanolamine, were mixed at a 9:1 unlabeled/
labeled ratio and 200 mM total lipid in 1.2 mL HEPES/MES buffer at pH 7.4
at 25C. After equilibration of the vesicles, 10–50 ml of a 1 mg/ml fusion
domain stock solution were added to give 3–15 mM ﬁnal protein con-
centrations. The ﬂuorescence before protein addition and after the addition
of 120 mL of 20% Triton X-100 to give 2% ﬁnal Triton X-100 were taken as
0 and 100% fusion, respectively. All experiments were performed in trip-
licates, and representative curves are shown.
Circular dichroism
Fusion domains in 5 mMHEPES, 10 mMMES buffer, pH 7.4 were added to
small unilamellar vesicles composed of POPC/POPG (4:1) or DPC (Avanti
Polar Lipid, Alabaster, AL) micelles at a ratio of 1:100 protein/lipid to give
0.1 mM protein and degassed for 5 min at room temperature before mea-
surements. CD spectra were collected at 25C on an AVIV model 215
spectropolarimeter (AVIV, Lakewood, NJ). The signals from pure small
unilamellar vesicles or DPCmicelles were subtracted from the sample spectra
as blanks. Helical fractions, fH, were estimated from the molar ellipticities at
222 nm, u222, and the expression fH¼(u222 895)/34,870,which is derived
from more general expressions applied to the length of our protein and the
measuring temperature (23,24).
Fourier transform infrared spectroscopy
The ATR-FTIR spectra were recorded on a Vector 22 Fourier transform
infrared spectrometer (Bruker, Billerica, MA). Planar phospholipid bilayers
supported on germanium ATR plates were prepared by Langmuir-Blodgett
deposition and fusion of small unilamellar vesicles as described previously
(25). The substrate-supported monolayer was 1,2-dimyristoyl-3-sn-phos-
phatidylcholine, and the monolayer exposed to the buffer compartment was
POPC/POPG (4:1). Fusion domains at 10 mg/ml in 5 mM HEPES, 10 mM
MES buffer, pH 7.4 were added to the sample cell, incubated for 5 min at
room temperature, and excess unbound protein was washed away with 3 vol
of the same buffer made in D2O.
Sample preparation for NMR
Peptides were dissolved into d38- DPC micelles in 20 mM d4-acetic acid pH
7 buffer (95% H2O/5% D2O), containing 5 mM dithiothreitol and 0.05%
NaN3. The ﬁnal
15N-labeled P23H8 samples contained 1 mM protein and
200 mM d38-DPC (Cambridge Isotope Laboratories), and the unlabeled
samples contained 2 mM peptide and 400 mM d38-DPC.
NMR spectroscopy
NMR spectra were recorded at 30C on Varian Innova 500 and 600 MHz
(Palo Alto, CA) and Bruker Avance 600 MHz spectrometers (Madison, WI)
equipped with triple-resonance z-gradient cryogenic probes. Resonances
were assigned from TOCSY (mixing times 50 and 80 ms), NOESY (mixing
times 80 and 120 ms), and 15N-HSQC-NOESY (mixing times 120 ms)
spectra. 3JHNHa couplings were measured using a three-dimensional HNHA
experiment (26). The f1Hg-15N heteronuclear NOEs were measured as
described with a 5-s saturation delay (27). All NMR spectra were processed
in NMRPipe (28) and analyzed in SPARKY (29).
Structure calculation
Dihedral angles f were calculated from experimental 3JHNHa couplings
according to
3
JHNa ¼ 6:4 cos2u 1:4 cosu1 1:9; (1)
where u ¼ jf  60j (30). Structures were calculated with the program
DYANA (31). The input consisted of the NOE upper distance constraints
878 Li and Tamm
Biophysical Journal 93(3) 876–885
and dihedral angle constraints derived from NOESY spectra using the
program HABAS and from the 3JHNHa experimental data, respectively. A
total of 300 structures were calculated, and the 40 lowest energy conformers
were selected for further optimization by using the AMBER force ﬁeld
implemented in the program OPAL (32). The resulting energy-minimized
conformers were used to represent the structure of the fusion domain in DPC
micelles.
Protein structure accession number
The coordinates of the structure of the HIV-1 gp41 fusion domain in DPC
micelles have been deposited in the Protein DataBank under accession No.
2PJV.
RESULTS AND DISCUSSION
Multiple strategies were pursued to obtain sufﬁcient amounts
of a soluble HIV fusion domain construct for structural and
biophysical studies on the interaction of these domains with
lipid bilayers. Preliminary studies with synthetic peptides
showed that a host peptide with a minimum of ﬁve lysines at
the C-terminus were necessary to solubilize the HIV fusion
domain; four lysines were sufﬁcient in the case of the in-
ﬂuenza HA fusion domain (20). Preliminary studies also
showed that homonuclear NMR with these constructs was
not sufﬁcient to resolve all resonances needed for a structure
determination. Therefore, we expressed and puriﬁed the 15N-
labeled fusion domain (P23H8) as a fusion protein with KSI
as outlined in Fig. 1 and described in more detail in Materials
and Methods. The KSI-HIV fusion protein, which also con-
tained a C-terminal His-tag for puriﬁcation, could be ex-
pressed in high yields. Typically, we obtained 35 mg of
fusion protein per liter of culture in minimal media. Initial
attempts to express P23H8 either by itself or as a fusion
protein with glutathione transferase failed. The fusion do-
main appears to be toxic to cells when expressed as a soluble
construct. However, when expressed as a fusion protein with
KSI, it is directed to inclusion bodies and apparently does
not interfere with cell growth. The KSI and His tags were
removed from P23H8 by cyanogen bromide cleavage, which
cleaves after methionines and converts the methionine into a
peptidyl homoserine lactone at the C-terminus of the target
protein (Fig. 1). To avoid internal cleavage of the HIV fusion
domain, methionine 19 was changed to a valine. This sub-
stitution did not affect CD or homonuclear NMR spectra in
lipid bilayers or DPC micelles (data not shown). The ﬁnal
product contained the ﬁrst 23 residues of the HIV-1 fusion
domain, followed by three glycines providing a ﬂexible linker,
and ﬁve lysines substituting for the ectodomain of gp41. The
fusion domain is soluble in various aqueous buffers, and
binds to lipid micelles and bilayers with high afﬁnity. We
anticipate that the general expression and puriﬁcation strat-
egy that was developed here for the HIV fusion domain will
also be useful for the preparation of other toxic hydrophobic
viral fusion domains and pore-forming bacterial toxins.
In our experience, high-resolution NMR spectra of viral
fusion domains can only be obtained when they are prepared
as soluble constructs that can be bound to lipid micelles or
bilayers from solution. Recombinants of detergents and pep-
tides prepared in organic solvent and subsequently hydrated
do not yield highly resolved NMR spectra in our hands. An
HSQC spectrum of the HIV fusion domain P23H8 in DPC
micelles obtained at 30C is shown in Fig. 2. This sample
was stable and its spectrum did not change for several months.
Cross-peaks for all residues of the P23 moiety except for Ala1
and Val2 are shown. The backbone and side-chain resonances
were assigned fromTOCSY,NOESY, and 15N-HSQCNOESY
experiments recorded at 600 MHz. The complete resonance
assignments are shown in Supplementary Material Table S1.
A total of 63 NOE upper distance constraints were ob-
tained from the NOESY and 15N-HSQC NOESY spectra.
Medium-range NOEs were observed between residues 3 and
15, indicating that this region is likely helical when the
fusion domain is bound to DPC micelles (Fig. 3). Negative
(positive) differences between the observed Ha (Hb) chem-
ical shifts and tabulated chemical shifts for random coil (33)
were present between residues 4 and 12, conﬁrming a helical
conformation of this segment (Fig. 4). Scalar 3JHNHa cou-
plings were obtained from a three-dimensional HNHA ex-
periment. Dihedral angles derived from these measurements
FIGURE 2 15N-1H HSQC spectrum of the HIV-1 gp41 fusion domain
bound to DPC micelles at 30C.
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are listed in Supplementary Material Table S2. Secondary
structures predicted based on these J-coupling- and chemical
shift-derived dihedral angles provide further evidence for a
high propensity of a-helix between residues 4 and 12 (Fig.
3). There was no evidence for ordered secondary structures
from Ala15 to Ser23. To conﬁrm that this latter segment did not
adopt a deﬁned secondary structure, we measured f1Hg-15N
heteronuclear NOEs of the fusion domain bound to DPC
micelles (Fig. 5). Relatively high values at ;0.6 indicating a
reasonably well-ordered structure were observed between Ile4
and Ala14. The heteronuclear NOEs gradually decreased from
Ala15 and reached negative values between Gly20 and Ser23,
conﬁrming a highly ﬂexible conformation at the C-terminus.
Therefore, all structural and dynamical parameters (NOEs,
chemical shifts, scalar couplings) consistently support a model
of the DPC-bound fusion domain with a relatively well-
ordered a-helix in the N-terminal portion and a disordered
region in the C-terminal portion of the domain.
Using the experimentally determined distance and dihe-
dral angle constraints, a structure of the micelle bound fusion
domain was calculated. Structural families of the N-terminal
portion (residues 1–18) and the entire domain (residues 1–24)
are presented in Fig. 6, a and b, respectively. The corre-
sponding structural statistics are presented in Table 1. Con-
sistent with the data of Fig. 5, residues 1–17 are quite well
ordered (heavy atom RMSD 1.00 6 0.23 A˚) and residues
4–14 are very well ordered (heavy atom RMSD 0.79 6
0.24 A˚). Fig. 6 c shows a typical structure with the side
chains inserted and Fig. 6 d shows the same structure in a
surface representation. This ﬁgure shows that the surface of
the helical portion of the HIV fusion domain is quite rough.
Several prominent features protrude from the surface, most
notably those formed by Phe8 and Phe11, but also those
of Ile4 and Leu9. Interestingly, the tandem FLG repeat of
the HIV fusion domain sequence is quite highly conserved
throughout many strains of HIV (34). Several depressions
are also seen on the surface, but they do not correspond to the
exact positions of the many glycines (marked with asterisks
in Fig. 6 d), which are also prominent in many fusion domain
sequences including those of HIV gp41 (35). The ﬁtting of
hydrophobic knobs into hydrophobic holes on membrane-
inserted helix surfaces is known to promote helix interactions
in membranes (36) and thus could provide a mechanism
for the gp41 fusion domain to interact with itself and/or the
transmembrane domain at different stages of membrane
fusion. An interaction of the fusion domain with the trans-
membrane domain has been postulated to be an important
late step in the mechanism of inﬂuenza hemagglutinin-
mediated membrane fusion (35).
FIGURE 3 Sequence, secondary structure propensities based on dihedral
bond angles, and NOE connectivities of the HIV-1 gp41 fusion domain
bound to DPC micelles at 30C. In the rows showing f- and c-dihedral
angles, triangles indicate a-helix or 310-helix, circles indicate random coil,
and f- and c-angles of residues marked with stars are consistent with either
a-helix or b-structure. In the row showing the x1 torsion angle, the sizes of
squares indicate whether the experimental values allow for one (large), two
(medium), or all three (small) staggered rotamer positions x1 ¼ 60, 60,
180. Torsion angle restraints that exclude all three rotamer positions are
shown as solid circles. The horizontal bars in the rows marked with d indi-
cate distances between respective protons that have been observed by mea-
surements of the corresponding NOEs.
FIGURE 4 Secondary chemical shifts of HIV-1 gp41 fusion domain
bound to DPC micelles at 30C. (Upper panel) Difference of Ha shifts
dobserved – drandom coil. (Lower panel) Difference of Hb shifts dobserved –
drandom coil.
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To examine whether the structure obtained in DPC micelles
is likely representative of the structure in lipid bilayers, we
recorded CD spectra in both environments and in solution
(Fig. 7). Based on these CD spectra, the HIV fusion domain
is unstructured in buffer with no or 0.2 M additional salt. The
HIV fusion domain adopts a partially helical structure with
characteristic CD minima at 208 and 222 nm when bound
to 10 mM DPC micelles. The CD spectra virtually did not
change in the peptide/lipid range 1:50–1:200, indicating
the high afﬁnity of the domain for these micelles and their
complete binding under these conditions (Supplementary
Material Fig. S1 A). All NMR spectra were recorded at 1:200
peptide/lipid, i.e., under saturating binding conditions. The
fusion domain is ;60% a-helical in DPC micelles based on
quantitative estimates of the CD spectra in this environment.
This a-helical content is consistent with the NMR structure
presented in Fig. 6. When bound to 10-mM lipid bilayers
composed of POPC and POPG (4:1), the negative molar
ellipticity increased further. A quantitative estimate indicates
that the a-helical content of the fusion domain is ;70%
in lipid bilayers. Clearly, bilayers are less dynamical than
lipid micelles, which could account for the increased he-
lical structure in bilayers. We estimate approximately four
more residues to be helical in bilayers compared to the micelle
structure.According to the dynamical data of Fig. 5,Gly3 at the
N-terminus and Ala15 through Thr18 at the C-terminal end of
the existing helix are themost likely to become ordered enough
to increase the lengthof the helix in lipid bilayers.CDspectra of
the fusion domain in 1MNaCl and in the absence of lipid were
also recorded. Under these conditions, the protein assumes
some, but not as much secondary structure as in DPCmicelles.
Presumably the screening of the charges of the pentalysine
tail used for solubilization lead to some aggregation with
an associated change in secondary structure in 1 M NaCl.
This experiment validates our design and reinforces why it is
essential to introduce this highly charged polar tail to keep the
fusion domain monodisperse for binding to lipid micelles
and bilayers and for structural studies. Similar effects were
observed with the fusion domains of inﬂuenza hemagglutinin,
which also self-associate in 1 M NaCl (37).
FIGURE 6 Structural models of HIV-1
gp41 fusion domain bound to DPCmicel-
les at 30C. (a) Forty lowest energy struc-
tures with ﬁrst 18 residues aligned. (b)
Same as panel a, but residues 1–24 are
shown. (c) Two different views of closest-
to-the-mean structure of residues 1–24
with side chains shown. (d) Same as panel
c, but only ﬁrst 18 residues in an elec-
trostatic surface potential representation.
Negative potentials are shown in red and
positive potentials are shown in blue. As-
terisks mark the positions of the Ca
atoms of glycines 3, 5, 10, 13, and 16.
FIGURE 5 f1Hg-15N heteronuclear NOEs of HIV-1 gp41 fusion domain
bound to DPC micelles at 30C.
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Previous studies indicated that the HIV fusion domain
may also assume b-structures in lipid bilayers (10,11,13–
15). To further characterize the secondary structure of this
domain in lipid bilayers, we recorded FTIR spectra of the
domain bound to planar supported bilayers composed of
POPC and POPG (4:1) as a function of protein concentra-
tion. Representative FTIR spectra in the amide I region are
shown in Fig. 8. A major broad band centered at ;1650
cm;1 dominates at all protein concentrations ranging from
10 to 40 mg/ml added protein. This band is commonly as-
signed to a-helical and random coil structures, which are not
easily distinguished from each other in FTIR spectroscopy
(25). However, a second band centered at 1630 cm1 in-
creases with increasing protein concentration. This band in-
dicates increasing amounts of b-structures and the small
shoulder at;1685 cm1 hints at antiparallel b-sheets. (Parallel
b-sheets do not exhibit this minor band, which in antiparallel
b-sheets is usually;10% of the intensity of the main band at
1630 cm1 (25)). Unfortunately, it is not straightforward to
determine the exact protein/lipid ratios at the membrane in
these single bilayer experiments for two reasons. First, the
experiments are conducted under much more dilute solution
conditions than the NMR and CD experiments so that we
cannot assume quantitative binding of all protein to the mem-
brane surface. For the same reason, a signiﬁcant amount of
the injected protein may adsorb nonspeciﬁcally to other sur-
faces than the membrane in the sample cell (opposite surface
of the holding cell, access tubing, etc.). Nevertheless, we can
make a very crude order-of-magnitude estimate. The exposed
membrane area in the holding cell corresponds to ;6 mM
lipid and 10 mg/ml is equivalent to a 3.4-mM injected protein
solution. If we assume that ;10% of the injected protein
actually binds to the membrane surface, we begin with a
protein/lipid ratio of ;1:20 and increase it to 4:20 as we
go to the highest concentration of 40 mg/ml added fusion
TABLE 1 Structural statistics of the HIV fusion domain in DPC
micelles at 30C
Target function (A˚) 0.25 6 0.001
Experimental NMR constraints
Total constraints 92





Sum (A˚) 1.2 6 0.0
Maximum (A˚) 0.18 6 0.00
Angle constraint violations
Sum (o) 11.4 6 0.0
Maximum (o) 2.9 6 0.0
AMBER energy (kcal/mol)
Root mean-square deviation from
mean structure (A˚)
Backbone atoms of all residues 1–24 3.45 6 1.28
Heavy atoms of all residues 1–24 3.84 6 1.24
Backbone atoms of residues 1–17 0.60 6 0.21
Heavy atoms of residues 1–17 1.00 6 0.23
Backbone atoms of residues 4–14 0.20 6 0.10





3–20; 100% for residues
4–17*
*90.9% in allowed region, 9.1% in additionally allowed region for residues
3–20; residues 4–17 are all in allowed region.
FIGURE 7 CD spectra of HIV-1 gp41 fusion domain in solution, bound
to DPC micelles, and bound to lipid bilayers composed of POPC/POPG
(4:1). (Solid line) 0.1 mM P23H8 in 5 mM HEPES, 10 mMMES buffer, pH
7.4. (Dash-dotted line) Same with 0.2 M NaCl added. (Dash-dot-dot line)
Same with 1 M NaCl added. (Dashed line) 0.1 mM P23H8 bound to 10 mM
DPC micelles. (Dotted line) 0.1 mM P23H8 bound to 10 mM POPC:POPG
(4:1) bilayers. All spectra were recorded at 25C.
FIGURE 8 ATR-FTIR spectra of HIV-1 gp41 fusion domain bound to
planar-supported lipid bilayers composed of POPC/POPG (4:1) at different
protein concentrations. (Solid line) Ten micrograms per milliliter P23H8
added to bilayer. (Dashed line) Twenty micrograms per milliliter P23H8
added to bilayer. (Dotted line) Thirty micrograms per milliliter P23H8 added
to bilayer. (Dash-dotted line) Forty micrograms per milliliter P23H8 added
to bilayer. All spectra were recorded at room temperature. The spectrum of
the pure bilayer recorded before the ﬁrst protein addition was subtracted
from each spectrum.
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domain. These are signiﬁcantly higher protein/lipid ratios
than used in the CD and NMR experiments of this work.
Clearly, increasing the protein concentration at the mem-
brane surface gradually converts the HIV fusion domain
to antiparallel b-structure by a membrane-assisted self-
association process. Self-association of fusion domains likely
occurred in numerous previous studies where b-structures
were reported for HIV fusion domains that were either not
initially dispersed by a polar tail, but mixed with lipids in
organic solvents, or extruded from lipid bilayers below their
gel-to-liquid-crystalline phase transition.
A structure of the gp41 fusion domain that has been
previously determined by solution NMR in SDS micelles is
even more helical than ours (17). The N-terminal portions of
the two structures are very similar, but the helix extends
further up to Gly20 in the Jaroniec et al. (17) structure. Ap-
parently, the relatively harsh ionic detergent SDS supports
the helical conformation. Before the present work, it was not
clear whether this structure was nonphysiologically induced
by SDS. The fact that we observe a similar structure in a
much more membranelike environment suggests that the
helical structure is indeed physiological. This is supported by
our CD and FTIR results, which also show helical confor-
mations at low protein concentrations in ﬂuid lipid model
membranes. There appear to be two major differences be-
tween the structures in SDS and DPC (Supplementary
Material Fig. S2). The helix is more extended toward the
C-terminus in SDS and there is an apparent break in the helix
around Gly10 in the DPC structure. Although we do not wish
to overinterpret details of these differences (some could be
due to dynamical differences and the number of collected
NMR restraints in the two environments), the primary chem-
ical shift data clearly indicate differences that for some
residues are quite signiﬁcant and for others more minor
(Supplementary Material Fig. S3). Interestingly, the chem-
ical shift trends seen in the titrations with DPC that were
performed by Jaroniec et al. (17), but that did not lead to
samples that were stable enough for a structure determina-
tion in this environment, extrapolate very nicely to the ﬁnal
chemical shifts that we observed in DPC (Supplementary
Material Fig. S3). Therefore, Jaroniec et al. (17) appear to
have recorded similar structural changes upon a partial
transfer into DPC, although they were not able to obtain a
structure under these conditions. An apparent detail of the
differences between the two structures is the break of the
helix at residue 10 in DPC, but not in SDS. However, closer
inspection of the complete families of structures calculated
in SDS and DPC shows that some DPC structures have a
continuous helix and some SDS structures also have a break
at this residue (17). The differences lie in the weights of
populations, rather than actual structural differences of this
region, in the two environments. The longer helix observed
in the SDS structure could be induced by the anionic and
much smaller headgroup of SDS compared to that of DPC or
by the longer fusion domain construct that was used by these
authors. Interestingly, our fusion domain construct is also
10–15% more helical in SDS than in DPC (Supplementary
Material Fig. S1 B). Given the conformational plasticity of
the HIV fusion domain in different environments as
documented in Figs. 6 and 7 and the Supplementary Material
ﬁgures, it is clear that details in sample preparation and
environment are important factors for determining the
functional structure of the HIV fusion domain in membranes.
To examine whether our fusion domain construct is able to
fuse lipid bilayer model membranes and which conformation
supports membrane fusion, we performed lipid mixing as-
says using a ﬂuorescence resonance energy transfer method.
Fusion domains alone usually give rise to leaky fusion, which
makes ﬂuorescent contents mixing assays not very useful
for this purpose. However, lipid mixing has been observed
for many active fusion domains (38), including that from
inﬂuenza hemagglutinin (20). Fig. 9 shows lipid mixing
and fusion between liposomes containing ﬂuorescent probes
that are quenched owing to resonance energy transfer and
unlabeled liposomes as catalyzed by the gp41 fusion domain.
Our soluble fusion domain construct P23H8 promoted efﬁ-
cient fusion between these liposomes. Control experiments
using only the solubilizing host peptide H7 did not induce
any lipid mixing or fusion. The rates and extents of fusion
increased in the concentration range from 3 to 6 mM P23H6
(Fig. 9). At 7 mM, overall fusion still increased compared to
5 mM, but discontinuities were often observed (Supplemen-
tary Material Fig. S4). When the concentration was further
increased, the dequenching decreased and the traces became
increasingly more noisy (Supplementary Material Fig. S4).
As was shown in Fig. 8, the a-helical form of the fusion
domain is preferred at low concentrations, but the b-sheet
form prevails when fusion domains are bound to membranes
FIGURE 9 Lipid mixing between labeled and unlabeled liposomes com-
posed of POPC/POPG (4:1) mediated by the HIV-1 gp41 fusion domain. Five
(a) or three (b) mM P23H8 was added to 200 mM liposomes at time 0 s. Five
mM of the control host peptide H7 (GCGKKKK) induces no lipid mixing (c).
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at high concentrations. The protein/lipid ratios in the exper-
iment of Fig. 9 were 1:40 or lower, which is in the range
where the a-helical form predominates. Signiﬁcant amounts
of b-sheet develop at protein/lipid ratios 1:20 and higher,
which corresponds to the 10 and 15 mM traces shown in
Supplementary Material Fig. S4. We conclude, therefore,
that the a-helical form promotes membrane fusion whereas
the b-sheet form is unable to induce a controlled fusion reac-
tion. The a-helical structure determined by solution NMR in
DPC micelles therefore likely represents the physiologically
active conformation of the HIV-1 gp41 fusion domain in
lipid bilayers.
SUPPLEMENTARY MATERIAL
An online supplement to this article can be found by visiting
BJ Online at http://www.biophysj.org.
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